Evidence map›Paper›PMID 38319104›Full record

ArticleJournal of virology2024

Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes.

Nicola Frericks, Richard J P Brown, Birthe M Reinecke, Maike Herrmann, Yannick Brüggemann, Daniel Todt, Csaba Miskey, Florian W R Vondran, Eike Steinmann, Thomas Pietschmann and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. SARS-CoV-2 mutant spectrum complexity is an epidemiologically evolvable trait.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Nicola FrericksInstitute for Experimental Virology, TWINCORE, Hannover, Germany.ORCID 0009-0007-6493-8187
Richard J P BrownDepartment for Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
Birthe M ReineckeInstitute for Experimental Virology, TWINCORE, Hannover, Germany.
Maike HerrmannDivision of Veterinary Medicine, Paul Ehrlich Institute, Langen, Germany.
Yannick BrüggemannDepartment for Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
Daniel TodtDepartment for Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
Csaba MiskeyDivision of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany.
Florian W R VondranDepartment for General, Visceral and Transplant Surgery, Hannover Medical School, Hannover, Germany.
Eike SteinmannDepartment for Molecular and Medical Virology, Ruhr-University Bochum, Bochum, Germany.
Thomas PietschmannInstitute for Experimental Virology, TWINCORE, Hannover, Germany.ORCID 0000-0001-6789-4422
Julie SheldonInstitute for Experimental Virology, TWINCORE, Hannover, Germany.ORCID 0000-0002-8240-0010
Center for Experimental and Clinical Infection Research · DEPaul Ehrlich Institut · DERuhr University Bochum · DEMedizinische Hochschule Hannover · DE

Funding

Genetic Viral and Host Adaptations to Breach Species Barriers of HCVR01AI107301 · NIAID · PRINCETON UNIVERSITY · PI Thomas Pietschmann, Alexander Ploss · 2013 to 2026
$6.0M
NIAID NIH HHS R01 AI107301
6 · The paper itself

Abstract

Hepatitis C virus (HCV) infection progresses to chronicity in the majority of infected individuals. Its high intra-host genetic variability enables HCV to evade the continuous selection pressure exerted by the host, contributing to persistent infection. Utilizing a cell culture-adapted HCV population (p100pop) which exhibits increased replicative capacity in various liver cell lines, this study investigated virus and host determinants that underlie enhanced viral fitness. Characterization of a panel of molecular p100 clones revealed that cell culture adaptive mutations optimize a range of virus-host interactions, resulting in expanded cell tropism, altered dependence on the cellular co-factor micro-RNA 122 and increased rates of virus spread. On the host side, comparative transcriptional profiling of hepatoma cells infected either with p100pop or its progenitor virus revealed that enhanced replicative fitness correlated with activation of endoplasmic reticulum stress signaling and the unfolded protein response. In contrast, infection of primary human hepatocytes with p100pop led to a mild attenuation of virion production which correlated with a greater induction of cell-intrinsic antiviral defense responses. In summary, long-term passage experiments in cells where selective pressure from innate immunity is lacking improves multiple virus-host interactions, enhancing HCV replicative fitness. However, this study further indicates that HCV has evolved to replicate at low levels in primary human hepatocytes to minimize innate immune activation, highlighting that an optimal balance between replicative fitness and innate immune induction is key to establish persistence. IMPORTANCE: Hepatitis C virus (HCV) infection remains a global health burden with 58 million people currently chronically infected. However, the detailed molecular mechanisms that underly persistence are incompletely defined. We utilized a long-term cell culture-adapted HCV, exhibiting enhanced replicative fitness in different human liver cell lines, in order to identify molecular principles by which HCV optimizes its replication fitness. Our experimental data revealed that cell culture adaptive mutations confer changes in the host response and usage of various host factors. The latter allows functional flexibility at different stages of the viral replication cycle. However, increased replicative fitness resulted in an increased activation of the innate immune system, which likely poses boundary for functional variation in authentic hepatocytes, explaining the observed attenuation of the adapted virus population in primary hepatocytes.

Indexed as

Genetic FitnessHepacivirusHepatocytesHost Microbial InteractionsImmunity, InnateMutationCells, CulturedEndoplasmic Reticulum StressHepatitis CHumansMicroRNAsSerial PassageUnfolded Protein ResponseViral TropismVirionVirus ReplicationMicroRNAsMIRN122 microRNA, humanhepatitis C virushost factorsinnate immunityvirus adaptation

Identifiers

PMID38319104
PMCPMC10949430
OpenAlexW4391576875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.